AccessibilityHelpAbout Us
Precision Peptide logo

Precision Peptide(OTC) PNGAF

Market Cap$14.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-87%
5 YearN/A
1 Year+16%
1 Month-9%
$0.31
+1.66%
+0.00Today
Precision Peptide last closing stock price
MetricPriceDate
Last closeUSD 0.302026-09-15
Precision Peptide stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.44%USD 0.322026-09-08
1 month-8.73%USD 0.332026-08-14
3 month-9.33%USD 0.332026-06-17
Year to date+45.9%USD 0.212025-12-31
1 year+15.85%USD 0.262025-09-04
3 year-56.69%USD 0.702023-08-28
Since inception-87.25%USD 2.362022-08-25

Precision Peptide Financials at a Glance

Market Cap

$14.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$109.17K

Net Income (TTM)

-CA$5.98M

EPS (TTM)

-$0.15

P/E Ratio

-2.02

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.31

Volume

450

Open

$0.32

Previous Close

$0.30

Daily Range

$0.31 - $0.32

52-Week Range

$0.01 - $0.50

Estimated Earnings Date

N/A

PNGAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precision Peptide

The Precision Peptide Company Inc. is a wellness-focused organization that specializes in the manufacture and distribution of peptide formulations and nutritional supplements. The company emphasizes non-invasive delivery systems aimed at health optimization, addressing areas such as stress management, gut health, longevity, and skin repair.

Products and Services
  • Peptide formulations for health optimization
  • Nutritional supplements targeting various wellness needs
  • Non-invasive delivery systems for effective absorption
Growth Outlook
  • Market demand for wellness products continues to rise
  • Focus on innovative delivery systems enhances competitive edge
  • Expansion into new consumer segments anticipated in upcoming quarters
Financial Highlights
  • Recent quarterly revenue of CAD 16,402 reflects ongoing challenges
  • Trailing twelve months (TTM) revenue shows a significant decline
  • Current ratio of 3.32 indicates strong short-term liquidity position
The Precision Peptide Company Inc. operates in a growing wellness market, with increasing consumer interest in health optimization products. Despite recent financial challenges, the company maintains a solid liquidity position, as evidenced by a current ratio of 3.32. The focus on innovative delivery systems positions the company favorably for future growth, particularly as market demand for wellness products continues to rise. Investors may find the company's commitment to health optimization and its potential for expansion into new consumer segments noteworthy.
AI Generated • Sep 14, 2026

Industry

Food Products

Sector

Consumer Staples

CEO

Pratapvir Sandhu

Website

www.pangeafood.com

Headquarters

Vancouver, BC V6C 1X8, CA

PNGAF Financials

Key Financial Metrics (TTM)

Gross Margin

-48.83%

Operating Margin

-4131.04%

Net Income Margin

-8804.16%

Return on Equity

-162.93%

Return on Capital

-242.25%

Return on Assets

-328.89%

Earnings Yield

-49.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

47.23M

Volume

450

Avg. Volume

49.68K

Financials (TTM)

Gross Profit

-CA$764.33K

Operating Income

-CA$3.71M

EBITDA

-CA$3.65M

Operating Cash Flow

-CA$2.65M

Capital Expenditure

-CA$5.46

Free Cash Flow

-CA$2.65M

Cash & ST Invst.

CA$772.97K

Total Debt

CA$0.00

Precision Peptide Performance Analysis

Precision Peptide annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31CAD 451,098728.8%
20232023-10-31CAD 211,736-53.1%
20242024-10-31CAD 8,963-95.8%
20252025-10-31CAD 35,505296.1%
Precision Peptide sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31N/A
Q42025-10-31640.3%
Q12026-01-31-1.7%
Q22026-04-30-61.9%
Precision Peptide annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31CAD -0.19535.1%
20232023-10-31CAD -0.2212.9%
20242024-10-31CAD -0.11-47.6%
20252025-10-31CAD -0.1531.7%
Precision Peptide sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-31-17.0%
Q42025-10-31-412.8%
Q12026-01-3158.9%
Q22026-04-3071.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$16.40K

N/A

Gross Profit

-CA$276.00

N/A

Gross Margin

-1.68%

N/A

Market Cap

$14.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$7.11M

N/A

Employees

2

N/A

Net Income

-CA$510.62K

-61.7%

EBITDA

-CA$479.23K

-79.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$772.97K

+433.7%

Total Debt

CA$0.00

-100.0%

Accounts Receivable

CA$82.05K

+87.8%

Inventory

CA$48.85K

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-3.29%

N/A

Return on Invested Capital

-2.21%

N/A

Free Cash Flow

-CA$862.98K

-53.7%

Operating Cash Flow

-CA$862.99K

-53.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GLUCGlucose Health, Inc.
$0.39+0.00%
AIXNAiXin Life International, Inc.
$0.26+0.00%
RELVReliv' International, Inc.
$1.46-6.77%
ARRTArtisan Consumer Goods, Inc.
$0.40+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MEDSDataMEDS Ai
$7.32+351.85%
RETOReTo Eco-Solutions
$10.52+275.75%
AALAmerican Airlines Group
$12.74-0.24%
NOKNokia
$10.21+3.76%

Questions About PNGAF

What is the current price of Precision Peptide?

Precision Peptide is trading at $0.31 per share.

What is the 52-week range for Precision Peptide?

Over the past 52 weeks, Precision Peptide has traded between $0.01 and $0.50.

How much debt does Precision Peptide have?

As of the most recent reporting period, Precision Peptide reported total debt of CA$0.00.

How much cash does Precision Peptide have on hand?

Precision Peptide reported CA$568.09K in cash and cash equivalents in its most recent financial results.

What is Precision Peptide’s dividend yield?

Precision Peptide does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services